PortalPublikationenSafety of sertindole versus risperidone in schizophrenia: pr...

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).

Standard

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). / Thomas, S H L; Drici, M D; Hall, G C; Crocq, M A; Everitt, B; Lader, M H; Le Jeunne, C; Naber, Dieter; Priori, S; Sturkenboom, M; Thibaut, F; Peuskens, J; Mittoux, A; Tanghøj, P; Toumi, M; Moore, N D; Mann, R D.

in: ACTA PSYCHIAT SCAND, Jahrgang 122, Nr. 5, 5, 2010, S. 345-355.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Thomas, SHL, Drici, MD, Hall, GC, Crocq, MA, Everitt, B, Lader, MH, Le Jeunne, C, Naber, D, Priori, S, Sturkenboom, M, Thibaut, F, Peuskens, J, Mittoux, A, Tanghøj, P, Toumi, M, Moore, ND & Mann, RD 2010, 'Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).', ACTA PSYCHIAT SCAND, Jg. 122, Nr. 5, 5, S. 345-355. <http://www.ncbi.nlm.nih.gov/pubmed/20384598?dopt=Citation>

APA

Thomas, S. H. L., Drici, M. D., Hall, G. C., Crocq, M. A., Everitt, B., Lader, M. H., Le Jeunne, C., Naber, D., Priori, S., Sturkenboom, M., Thibaut, F., Peuskens, J., Mittoux, A., Tanghøj, P., Toumi, M., Moore, N. D., & Mann, R. D. (2010). Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). ACTA PSYCHIAT SCAND, 122(5), 345-355. [5]. http://www.ncbi.nlm.nih.gov/pubmed/20384598?dopt=Citation

Vancouver

Thomas SHL, Drici MD, Hall GC, Crocq MA, Everitt B, Lader MH et al. Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). ACTA PSYCHIAT SCAND. 2010;122(5):345-355. 5.

Bibtex

@article{faed87d231de4529b121a210f9d91af6,
title = "Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).",
abstract = "To explore whether sertindole increases all-cause mortality or cardiac events requiring hospitalization, compared with risperidone.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, numerical data, Adolescent, Young Adult, Prospective Studies, Proportional Hazards Models, Hospitalization statistics, Schizophrenia drug therapy, Antipsychotic Agents adverse effects, Arrhythmias, Cardiac chemically induced, Heart Diseases chemically induced, Imidazoles adverse effects, Indoles adverse effects, Risperidone adverse effects, Suicide, Attempted statistics, Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, numerical data, Adolescent, Young Adult, Prospective Studies, Proportional Hazards Models, Hospitalization statistics, Schizophrenia drug therapy, Antipsychotic Agents adverse effects, Arrhythmias, Cardiac chemically induced, Heart Diseases chemically induced, Imidazoles adverse effects, Indoles adverse effects, Risperidone adverse effects, Suicide, Attempted statistics",
author = "Thomas, {S H L} and Drici, {M D} and Hall, {G C} and Crocq, {M A} and B Everitt and Lader, {M H} and {Le Jeunne}, C and Dieter Naber and S Priori and M Sturkenboom and F Thibaut and J Peuskens and A Mittoux and P Tangh{\o}j and M Toumi and Moore, {N D} and Mann, {R D}",
year = "2010",
language = "Deutsch",
volume = "122",
pages = "345--355",
journal = "ACTA PSYCHIAT SCAND",
issn = "0001-690X",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).

AU - Thomas, S H L

AU - Drici, M D

AU - Hall, G C

AU - Crocq, M A

AU - Everitt, B

AU - Lader, M H

AU - Le Jeunne, C

AU - Naber, Dieter

AU - Priori, S

AU - Sturkenboom, M

AU - Thibaut, F

AU - Peuskens, J

AU - Mittoux, A

AU - Tanghøj, P

AU - Toumi, M

AU - Moore, N D

AU - Mann, R D

PY - 2010

Y1 - 2010

N2 - To explore whether sertindole increases all-cause mortality or cardiac events requiring hospitalization, compared with risperidone.

AB - To explore whether sertindole increases all-cause mortality or cardiac events requiring hospitalization, compared with risperidone.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - numerical data

KW - Adolescent

KW - Young Adult

KW - Prospective Studies

KW - Proportional Hazards Models

KW - Hospitalization statistics

KW - Schizophrenia drug therapy

KW - Antipsychotic Agents adverse effects

KW - Arrhythmias, Cardiac chemically induced

KW - Heart Diseases chemically induced

KW - Imidazoles adverse effects

KW - Indoles adverse effects

KW - Risperidone adverse effects

KW - Suicide, Attempted statistics

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - numerical data

KW - Adolescent

KW - Young Adult

KW - Prospective Studies

KW - Proportional Hazards Models

KW - Hospitalization statistics

KW - Schizophrenia drug therapy

KW - Antipsychotic Agents adverse effects

KW - Arrhythmias, Cardiac chemically induced

KW - Heart Diseases chemically induced

KW - Imidazoles adverse effects

KW - Indoles adverse effects

KW - Risperidone adverse effects

KW - Suicide, Attempted statistics

M3 - SCORING: Zeitschriftenaufsatz

VL - 122

SP - 345

EP - 355

JO - ACTA PSYCHIAT SCAND

JF - ACTA PSYCHIAT SCAND

SN - 0001-690X

IS - 5

M1 - 5

ER -